1. PD-1 blockade induces responses by inhibiting adaptive immune resistance;Tumeh;Nature,2014
2. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients;Herbst;Nature,2014
3. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy;Taube;Clin Cancer Res,2014
4. The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the streptococcus erysipelas and the Bacillus prodigiosus);Coley;Proc R Soc Med,1910
5. The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research;Nauts;Cancer Res,1946